期刊文献+

Endoglin和脾酪氨酸激酶在胃癌组织中的表达及意义 被引量:9

Significance and expression of endoglin and spleen tyosine ldnase in gastric carcinoma
原文传递
导出
摘要 目的观察胃癌组织中Endoglin标记的微血管密度计数(MVD)和脾酪氨酸激酶(Syk)的表达。方法应用免疫组织化学法检测50例胃癌患者手术切除的癌组织和癌旁组织中Endoglin标记的MVD和Syk表达水平。结果Endoglin标记的MVD胃癌组织的表达强度为(62.62±4.08),明显高于癌旁组织的表达强度(45.79±3.37),两者差异有统计学意义(P〈0.01);Syk胃癌组织的阳性表达率为44.00%(22/50),明显低于癌旁组织阳性表达率92.00%(46/50),两者差异有统计学意义(P〈0.01);Endoglin标记的MVD表达强度与胃癌TNM分期、组织学分化程度、淋巴结转移明显相关(P〈0.05),Syk表达水平与胃癌TNM分期、淋巴结转移明显相关(P〈0.05)。结论胃癌组织中Endoglin和Syk表达水平的检测有助于判断胃癌病情和预后。 Objective To study the expression of Microvessel density (MVD) marked with En- doglin and spleen tyosine kinase (Syk) in gastric carcinoma. Methods The expression levels of MVD marked with endoglin and Syk in gastric carcinoma tissues and adjacent normal gastric tissues (8 cm dis- tance away from the margin of gastric carcinoma) were examined by using immunohistochemical method. Results The expression of MVD marked with endoglin was (62. 62 ± 4. 08) in gastric carcinoma tissues, and (45.79 +3.37) in non-cancerous adjacent gastric tissues (P 〈0.01 ), the expression rate of Syk was 44. 00% (22/50) in gastric carcinoma tissues, and 92. 00% (46/50) in non-cancerous adjacent gastric tissues (P 〈0. 01 ) ; the expressions of MVD were related to TNM stage, histology grade and lymph node metastasis ( P 〈 0. 05 ), the expressions of Syk were related to TNM stage and lymph node metastasis (P 〈 0. 05). Conclusion These results demonstrate that determination of Endoglin and Syk may be value in making diagnosis, evluating evlution of disease in patients with gastric carcinoma.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第2期227-228,共2页 Chinese Journal of Experimental Surgery
关键词 ENDOGLIN 微血管密度 脾酪氨酸激酶 胃癌 免疫组织化学法 Endoglin Microvessel density Spleen tyosine kinase Gastric carcinoma Immunohistochemical method
  • 相关文献

参考文献5

二级参考文献33

  • 1马军,郭敏,李印,唐芙爱,虎建恩,段芳龄.食管鳞癌中TGF-β及其受体调节成分Endoglin/CD105的表达[J].第四军医大学学报,2006,27(14):1308-1311. 被引量:4
  • 2Saad RS, Liu YL, Nathan G,, et al. Endoglin ( CD105 ) and vascular endothelial growth factor as prognostic markers in colorectal cancer. Mod Patho1,2004,17 : 197-203.
  • 3Kumar S, Ghellal A, Li C, et al. Breast carcinoma: vascular density de- termined using CD105 antibody correlates with tumor prognosis. Cancer Res, 1999,59:856-861.
  • 4Sehimming R, Marine D. Endoglin(CD105) expression in squamous cell carcinoma of the oral cavity. Head Neck ,2002,24:151-156.
  • 5Munoz R, Arias Y, Ferreras JM, et al. Targeting a marker of the tumour neovasculature using a novel anti-human CDlOS-immanotoxin containing the non-toxic type2 ribosome-inactivating protein nigrinb. Cancer Lett, 2007,256 : 73 -80.
  • 6Lee SH, Mizutani N, Mizutani M ,et al. Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer. Cancer Immunol Immunother, 2006,55 : 1565 -1574.
  • 7Seon BK Takahashi N, Haba A, et al. Angiogenesis and metastasis marker of human tumors. Rinsho Byori ,2001,49 : 1005-1013.
  • 8Bellone G, Solerio D, Chiusa L, et al. Transforming growth factor-beta binding receptor endoglin ( CD105 ) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence [ J ]. Ann Surg Oncol, 2007,14 ( 11 ) :3232 - 3242.
  • 9El-Gohary YM, Silverman JF, Olson PR, et al. Endoglin ( CD105 ) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma[ J ]. Am J Clin Pathol,2007 ,127 (4) :572 - 579.
  • 10Gibbs CP, Kukekov VG, Reith JD,et al. Stem-like cells in bone sarcomas : implications for tumorigenesis [ J ]. Neoplasia, 2005,7 ( 11 ) :967 -976.

共引文献61

同被引文献51

  • 1Liang QL,Wang BR,Li ZY,ct al.Construction of eukaryotic expression vector of TSLC1 gene[J].Arch Med Sci,2011,7(4):579-585.
  • 2Miceli C,Tejada A,Castaneda A. Cell cycle inhibition therapy that targets stathmin in in vitro and in vivo models of breast cancer[J].{H}Cancer Gene Therapy,2013,(5):298-307.
  • 3Sonego M,Schiappacassi M,Lovisa S. Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer[J].EMBO Mol Med,2013,(5):707-722.
  • 4Liu QL,Liang QL,Li ZY. Function and expression of prolyl hydroxylase 3 in cancers[J].Arch Med Sci,2013,(4):589-593.
  • 5Jeon TY,Han ME,Lee YW. Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells[J].{H}British Journal of Cancer,2010,(4):710-718.
  • 6Chen R, Zhuge X, Huang Z, et al. Analysis of SEMA3B methylation and expression patterns in gastric cancer tis- sue and cell lines[J]. Oncol Rep,2014,31(3):1211-1218.
  • 7Liu J,Zhu X,Xu X,et al. DNA promoter and histone H3 methylation downregulate NGX6 in gastric cancer cells [J]. Med Oncol,2014,31(1) :817-821.
  • 8Bloom BR,Bennettm B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity[J]. Science, 1966,153 (16) . 80-82.
  • 9Ren Y, Tsui HT, Poon RP, et al. Macrophage migration inhibitory factor., roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular car- cinoma[J]. Int J cancer,2003,107(16) .22-29.
  • 10Taskiran C,Erdem O,Onan A,et al. The prognostic value of endoglin (CD105) expression in ovarian carcinoma[J]. Int J Gynecol Cancer,2006,16(5) . 1789-1793.

引证文献9

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部